Macular Degeneration


March 1st, 2019 - March 1st, 2022
1.00 AMA PRA Category 1 Credit Hours

Description

Today on MedNet21, we're going to discuss Macular Degeneration.

The first half of this activity will cover the epidemiology of macular degeneration and dry macular degeneration. The second half of this activity will cover diagnosis and treatment of wet macular
degeneration.

Pre-Test taking for this webcast is no longer available.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 3/1/2022

Objectives

As a result of this educational activity, webcast participants will be able to:  REVIEW Characteristics of Age-Related Macular Degeneration; DISCUSS Modifiable Risk Factors that can Lead to Prevention of Disease; DEFINE neovascular macular degeneration; and DISCUSS the diagnosis and management of wet macular degeneration.

You’ll also learn about the following:

  • Risk factors for macular degeneration
  • Prognosis of macular degeneration
  • Screening for macular degeneration in the primary care office
  • Assessing risks when starting a patient on anticoagulation

Webcasts Files

File Link

Macular Degeneration - 2

Download

Macular Degeneration - 4

Download

Macular Degeneration - 2 - color

Download

Disclosure Information for Planning Committee Members and Speakers

Download

Speakers

  • Dr. Matthew Ohr, MD
    • Macular Degeneration
  • Dr. Fatoumata Yanoga, MD
    • Macular Degeneration

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.